FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/07/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
INVENTIA
ST13
US500000079385808Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Localização atual
Titulares
Representantes
Robyn S. Lederman Brooks Kushman PC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 7
3D printers; computerized printers for the generation of 3D shaped parts; machines, namely, 3D bioprinters for the printing of living cells and tissues or printing 3D cell structures; cartridges being parts of 3D printers for containing printing materials; cartridges being parts of 3D printers for containing bioprinting materials; printing cartridges being parts of 3D printers for containing biomaterials and reagents; printing cartridges being parts of 3D printers for containing bio-ink; robotic handling apparatus, namely, robotic handling apparatus and arms for industrial and commercial use; accessories and spare parts for three dimensional (3D) printers for the production of biological materials, namely, print heads for three dimensional (3D) printers; machines, namely, three dimensional (3D) printer for the printing of engineered living tissues; three dimensional (3D) printers; structural parts and fittings therefor * ; none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders (including obesity, diabetes, severe dyslipidemias, NASH), inflammatory diseases and autoimmune diseases *
Classe 9
Laboratory robots; downloadable software for monitoring and controlling communication between computers and automated machine systems; downloadable software for operating and controlling 3D printers; downloadable operating software to control laboratory apparatus for fabrication of three dimensional (3D) engineered living tissues; downloadable software for the purpose of the manufacture of products by means of a 3D printer, including medical products; laboratory instruments and apparatus, namely, cell assembly apparatus for laboratory use for fabrication of three dimensional (3D) engineered living tissues; print heads for 3D printers and bioprinters; downloadable electronic publications, namely, pamphlets, brochures, journals, books, manuals, newsletters and booklets in the field of living tissue, tissue regeneration, 3D printing, cell printing, cell assembly and biomedical research; parts and fittings for all of the foregoing, namely, electronic control panels with digital displays for the control of three dimensional (3D) printers, printer cables, and ink cartridges, unfilled, for printers * ; none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders (including obesity, diabetes, severe dyslipidemias, NASH), inflammatory diseases and autoimmune diseases *
Classe 10
Surgical robots, namely, robotic apparatus for medical or surgical purposes; surgical robots; surgical robots for medical purposes; medical apparatus for use in soft tissue repair, reconstruction of soft tissue deficiencies, regenerative surgery, plastic reconstructive surgery and wound healing in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research; structural parts and fittings therefor; none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders, obesity, diabetes, severe dyslipidemias, NASH, inflammatory diseases and autoimmune diseases
Classe 35
Data management; wholesale and retail store services for pharmaceutical, medical, scientific, laboratory and 3D printing consumables and supplies; online wholesale and retail store services featuring pharmaceutical, medical, scientific, laboratory and 3D printing consumables and supplies; administrative processing of purchase orders; order fulfillment services, namely, computerised stock ordering and purchasing; computerised data processing; compiling and analyzing statistics, data and other sources of scientific information for business purposes; computerised register management, namely, maintenance of registers for others * none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders (including obesity, diabetes, severe dyslipidemias, NASH), inflammatory diseases and autoimmune diseases *
Classe 42
Scientific and technological services and research and design relating thereto, all in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research; industrial analysis, industrial research and industrial design services, all in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research; design and development of computer software; software as a service (SAAS) services, namely, hosting software for use by others in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research and to identify, select and print biomaterials for the purpose of experiments; providing online non-downloadable software for use by others in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research and to identify, select and print biomaterials for the purpose of experiments; computer support services, namely, computer programming and software installation, repair and maintenance services; scientific research services, specifically, analysis of statistical data for scientific research purposes; design of software; design and development of new products in the field of biological materials; visual design services in the nature of designing visual elements for print media; new product design services; scientific research relating to design in the field of 3D printing, bioprinting, cell printing, cell assembly and biomedical research; laboratory research in the field of biomedical research, bioprinting, cell printing, cell assembly and the creation and engineering of 3D cells and living tissues; biomedical research; cloud computing featuring software for use in the field of living tissue, tissue regeneration, 3D printing, bioprinting, cell printing, cell assembly and biomedical research and to identify, select and print biomaterials for the purpose of experiments; technical consultancy in the field of scientific research; scientific research in the field of soft tissue repair, reconstruction of soft tissue deficiencies, regenerative surgery, plastic reconstructive surgery, wound healing, drug discovery, genetics, dermatology and oncology; scientific research into the development of new products; technical support services, namely, troubleshooting in the nature of repair of medical equipment and diagnostic laboratory instruments and systems; providing online non-downloadable web-based computer software platforms for laboratory and diagnostic equipment information management, monitoring and analysis; providing information and online information regarding the foregoing; none of the foregoing being in relation to oral or injectable therapies for the treatment of patient needs in the areas of fibrosis, lysosomal storage disorders and oncology, cardiometabolic diseases, liver diseases, metabolic disorders (including obesity, diabetes, severe dyslipidemias, NASH), inflammatory diseases and autoimmune diseases
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
FINAL DISPOSITION NOTICE SENT TO IB
23/07/2026
FINAL DISPOSITION PROCESSED
23/07/2026
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
07/07/2026
LIMITATION FROM THE IB EXAMINED AND ENTERED
17/06/2026
CORRECTION UNDER SECTION 7 - PROCESSED
17/06/2026
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17/06/2026
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/04/2026
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/01/2026
REGISTERED-PRINCIPAL REGISTER
20/01/2026
LIMITATION OF GOODS RECEIVED FROM IB
25/12/2025
NOTIFICATION PROCESSED BY IB
11/12/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/12/2025
PUBLISHED FOR OPPOSITION
02/12/2025
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/11/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/11/2025
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/11/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
31/10/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
27/10/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/10/2025
TEAS REQUEST FOR RECONSIDERATION RECEIVED
27/10/2025
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/06/2025
LIMITATION OF GOODS RECEIVED FROM IB
23/05/2025
NOTIFICATION OF FINAL REFUSAL EMAILED
22/05/2025
FINAL REFUSAL E-MAILED
22/05/2025
FINAL REFUSAL WRITTEN
22/05/2025
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/05/2025
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
20/05/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
15/04/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/04/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/04/2025
LIMITATION OF GOODS RECEIVED FROM IB
28/03/2025
REFUSAL PROCESSED BY IB
23/11/2024
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/11/2024
REFUSAL PROCESSED BY MPU
04/11/2024
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/10/2024
NON-FINAL ACTION WRITTEN
29/10/2024
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
22/10/2024
NEW REPRESENTATIVE AT IB RECEIVED
30/08/2024
NEW REPRESENTATIVE AT IB RECEIVED
23/08/2024
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/03/2024
NON-FINAL ACTION WRITTEN
23/03/2024
ASSIGNED TO EXAMINER
22/03/2024
APPLICATION FILING RECEIPT MAILED
26/12/2023
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/12/2023
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/12/2023
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.